• Something wrong with this record ?

Basal and Activated Calcium Sensitization Mediated by RhoA/Rho Kinase Pathway in Rats with Genetic and Salt Hypertension

M. Behuliak, M. Bencze, I. Vaněčková, J. Kuneš, J. Zicha,

. 2017 ; 2017 (-) : 8029728. [pub] 20170119

Language English Country United States

Document type Journal Article

Persistent link   https://www.medvik.cz/link/bmc17013264

Grant support
NV15-25396A MZ0 CEP Register

Calcium sensitization mediated by RhoA/Rho kinase pathway can be evaluated either in the absence (basal calcium sensitization) or in the presence of endogenous vasoconstrictor systems (activated calcium sensitization). Our aim was to compare basal and activated calcium sensitization in three forms of experimental hypertension with increased sympathetic tone and enhanced calcium entry-spontaneously hypertensive rats (SHR), heterozygous Ren-2 transgenic rats (TGR), and salt hypertensive Dahl rats. Activated calcium sensitization was determined as blood pressure reduction induced by acute administration of Rho kinase inhibitor fasudil in conscious rats with intact sympathetic nervous system (SNS) and renin-angiotensin system (RAS). Basal calcium sensitization was studied as fasudil-dependent difference in blood pressure response to calcium channel opener BAY K8644 in rats subjected to RAS and SNS blockade. Calcium sensitization was also estimated from reduced development of isolated artery contraction by Rho kinase inhibitor Y-27632. Activated calcium sensitization was enhanced in all three hypertensive models (due to the hyperactivity of vasoconstrictor systems). In contrast, basal calcium sensitization was reduced in SHR and TGR relative to their controls, whereas it was augmented in salt-sensitive Dahl rats relative to their salt-resistant controls. Similar differences in calcium sensitization were seen in femoral arteries of SHR and Dahl rats.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc17013264
003      
CZ-PrNML
005      
20170418103321.0
007      
ta
008      
170413s2017 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1155/2017/8029728 $2 doi
035    __
$a (PubMed)28197417
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Behuliak, Michal $u Institute of Physiology, Czech Academy of Sciences, Prague, Czech Republic.
245    10
$a Basal and Activated Calcium Sensitization Mediated by RhoA/Rho Kinase Pathway in Rats with Genetic and Salt Hypertension / $c M. Behuliak, M. Bencze, I. Vaněčková, J. Kuneš, J. Zicha,
520    9_
$a Calcium sensitization mediated by RhoA/Rho kinase pathway can be evaluated either in the absence (basal calcium sensitization) or in the presence of endogenous vasoconstrictor systems (activated calcium sensitization). Our aim was to compare basal and activated calcium sensitization in three forms of experimental hypertension with increased sympathetic tone and enhanced calcium entry-spontaneously hypertensive rats (SHR), heterozygous Ren-2 transgenic rats (TGR), and salt hypertensive Dahl rats. Activated calcium sensitization was determined as blood pressure reduction induced by acute administration of Rho kinase inhibitor fasudil in conscious rats with intact sympathetic nervous system (SNS) and renin-angiotensin system (RAS). Basal calcium sensitization was studied as fasudil-dependent difference in blood pressure response to calcium channel opener BAY K8644 in rats subjected to RAS and SNS blockade. Calcium sensitization was also estimated from reduced development of isolated artery contraction by Rho kinase inhibitor Y-27632. Activated calcium sensitization was enhanced in all three hypertensive models (due to the hyperactivity of vasoconstrictor systems). In contrast, basal calcium sensitization was reduced in SHR and TGR relative to their controls, whereas it was augmented in salt-sensitive Dahl rats relative to their salt-resistant controls. Similar differences in calcium sensitization were seen in femoral arteries of SHR and Dahl rats.
650    _2
$a zvířata $7 D000818
650    _2
$a geneticky modifikovaná zvířata $7 D030801
650    _2
$a vápník $x aplikace a dávkování $x metabolismus $7 D002118
650    _2
$a lidé $7 D006801
650    _2
$a hypertenze $x etiologie $x genetika $x metabolismus $x patologie $7 D006973
650    _2
$a krysa rodu Rattus $7 D051381
650    _2
$a potkani inbrední Dahl $7 D020303
650    _2
$a potkani inbrední SHR $7 D011918
650    _2
$a signální transdukce $x účinky léků $7 D015398
650    _2
$a sympatický nervový systém $x metabolismus $x patologie $7 D013564
650    _2
$a vazokonstrikce $x genetika $7 D014661
650    _2
$a kinázy asociované s rho $x antagonisté a inhibitory $x genetika $7 D054460
655    _2
$a časopisecké články $7 D016428
700    1_
$a Bencze, Michal $u Institute of Physiology, Czech Academy of Sciences, Prague, Czech Republic.
700    1_
$a Vaněčková, Ivana $u Institute of Physiology, Czech Academy of Sciences, Prague, Czech Republic.
700    1_
$a Kuneš, Jaroslav $u Institute of Physiology, Czech Academy of Sciences, Prague, Czech Republic.
700    1_
$a Zicha, Josef $u Institute of Physiology, Czech Academy of Sciences, Prague, Czech Republic.
773    0_
$w MED00182164 $t BioMed research international $x 2314-6141 $g Roč. 2017, č. - (2017), s. 8029728
856    41
$u https://pubmed.ncbi.nlm.nih.gov/28197417 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20170413 $b ABA008
991    __
$a 20170418103629 $b ABA008
999    __
$a ok $b bmc $g 1199729 $s 974042
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2017 $b 2017 $c - $d 8029728 $e 20170119 $i 2314-6141 $m BioMed research international $n Biomed Res Int $x MED00182164
GRA    __
$a NV15-25396A $p MZ0
LZP    __
$a Pubmed-20170413

Find record

Citation metrics

Archiving options